Omeprazole/amoxicillin/rifabutin

Omeprazole/amoxicillin/rifabutin, sold under the brand name Talicia, is a fixed-dose combination medication used for the treatment of Helicobacter pylori infection. It is taken by mouth.

It was approved for medical use in the United States in November 2019.

References

External links

• "Omeprazole". Drug Information Portal. U.S. National Library of Medicine.
• "Amoxicillin". Drug Information Portal. U.S. National Library of Medicine.
• "Rifabutin". Drug Information Portal. U.S. National Library of Medicine.
• Clinical trial number NCT03198507 for "ERADICATE Hp2 - Treating Helicobacter Pylori With RHB-105 Compared to Active Comparator (ERADICATE Hp2)" at ClinicalTrials.gov
• Clinical trial number NCT01980095 for "ERADICATE Hp - Treating Helicobacter Pylori With RHB-105 (ERADICATE Hp)" at ClinicalTrials.gov

1. Helicobacter pylori eradication protocols
2. WHO Model List of Essential Medicines
3. ATC code A02
4. List of MeSH codes (D03)